TheEdgeResearch
Home / Stocks / MJARF

MJardin Group, Inc. (MJARF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$90,140
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.62
52-Wk Range
0.000001-0.0001
CEO
Ali Mahdavi
Country
CA
Currency
USD

MJardin Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $90,140. Its beta of 0.62 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
0
IPO date
2018-11-16
Headquarters
Toronto, ON, CA
About MJardin Group, Inc.

MJardin Group Inc. is a company actively involved in the cultivation, harvesting, processing, and sale of cannabis products throughout Canada and the United States. Beyond its own product lines, MJardin extends its expertise by offering a comprehensive suite of consulting and advisory services to other licensed cannabis operators, specifically those engaged in cultivation and retail. This support covers a broad spectrum, including strategic capital and financing, project management for cultivation facilities, assistance with licensure, facility design, system implementation, property and equipment leasing, construction oversight, and the critical operational ramp-up phase. The company also provides access to its proprietary intellectual property. MJardin's influence spans a portfolio of 32 cannabis operations, which it either owns, manages, or provides guidance for. Established in 2014, the company maintains its headquarters in Ontario, Canada.

More research on MJARF
MJARF technical analysis MJARF TheEdge Score Compare against peers
Open full interactive analysis & DCF →